ASP Isotopes Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
3analysts covering
FY Revenue (est.)
$31.3Mnext fiscal year
FY EPS (est.)
-$1.44next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 14 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Silicon-28 Commercial Shipments QuarterlyTarget: Initial commercial shipments to begin in Q3 2026
Radiopharmacy Revenue Annually5.7MTarget: 10000000 or more in 2026
Long-Term EBITDA Target AnnuallyTarget: Greater than 300 million in 2031
Watch Items
- Silicon-28 Pretoria Facility Commercial ShipmentsTrigger: Q3 2026 target shipment dateAction: Verify successful delivery and customer acceptance of enriched Silicon-28 to U.S.-based customers.
- Quantum Leap Energy (QLE) Spin-off and U.S. ListingTrigger: Confidential S-1 submission statusAction: Monitor SEC updates regarding the public filing and potential IPO of the QLE business segment.
- HALEU Supply Chain Collaboration and Definitive AgreementsTrigger: MOU with large U.S. energy company and TerraPower agreementsAction: Track conversion of non-binding MOUs into binding commercial contracts and funding milestones.
Research as of 19 Jun 2026